- Pilot and Feasibility Program The purpose of the Michigan Diabetes Research Center (MDRC) Pilot and Feasibility (P/F) Grants Program is to stimulate new research in the areas of diabetes, its complications, and related endocrine and metabolic disorders. This research may be in areas of basic biomedical science or clinical research. This program provides a minimum of $250,000 per year for P/F grant awards; additional funding may be provided for highly-rated applications using funds provided by the University of Michigan. The MDRC P/F program will fund two types of awards: (1) standard one-year $50,000 P/F awards with a single PI, and (2) two-year, $100,000 Diabetes Interdisciplinary Studies Program (DISP) awards that seek to support and promote new collaborations between two or more University of Michigan (UM) faculty members from distinct disciplines, to focus their combined research strengths on cutting-edge areas in diabetes research. Each year, the MDRC solicits applications for P/F and DISP grants from full-time instructional or research faculty at UM. Those eligible include: 1) new investigators without past or current NIH research support who are beginning careers in diabetes research, 2) established investigators who have not previously worked in diabetes research but wish to focus their expertise on diabetes, and 3) established diabetes investigators who propose innovative research in diabetes that represents a clear departure from their ongoing research. Highest priority is given to new investigators. Applications are actively solicited from across the university and are peer-reviewed by two or more extramural reviewers with expertise in the area of the application. Grant applications with the highest merit, as judged by this review process and the intramural Grants Program Advisory Council, receive awards. The balance of standard P/F and DISP awards may vary from year to year, depending upon the relative strength of applications for each award type. The ultimate goal of the program is to enable awardees to generate sufficient preliminary data to support a successful application for major research funding from the NIH or another national granting agency. The P/F Grants Program attracts investigators from diverse schools, departments, and institutes into diabetes research and fosters new, innovative, interdisciplinary, and collaborative diabetes research at UM.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK020572-44
Application #
10071183
Study Section
Special Emphasis Panel (ZDK1)
Project Start
1996-12-01
Project End
2022-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
44
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Nielsen, Jonas B; Fritsche, Lars G; Zhou, Wei et al. (2018) Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development. Am J Hum Genet 102:103-115
Sahinoz, Melis; Khairi, Shafaq; Cuttitta, Ashley et al. (2018) Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis. Clin Diabetes Endocrinol 4:6
Fan, Yanbo; Lu, Haocheng; Liang, Wenying et al. (2018) Endothelial TFEB (Transcription Factor EB) Positively Regulates Postischemic Angiogenesis. Circ Res 122:945-957
Zeng, Lixia; Mathew, Anna V; Byun, Jaeman et al. (2018) Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis. J Biol Chem 293:7238-7249
Jadoon, Adil; Mathew, Anna V; Byun, Jaeman et al. (2018) Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients. Am J Nephrol 48:269-277
Turcot, Valérie (see original citation for additional authors) (2018) Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet 50:26-41
Harvey, Innocence; Stephenson, Erin J; Redd, JeAnna R et al. (2018) Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice. Endocrinology 159:2275-2287
Callaghan, Brian C; Xia, Rong; Reynolds, Evan et al. (2018) Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists. Clin Neurophysiol 129:654-662
Ruebsam, Anne; Dulle, Jennifer E; Myers, Angela M et al. (2018) A specific phosphorylation regulates the protective role of ?A-crystallin in diabetes. JCI Insight 3:
An, Duo; Chiu, Alan; Flanders, James A et al. (2018) Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes. Proc Natl Acad Sci U S A 115:E263-E272

Showing the most recent 10 out of 1823 publications